Headquarters: Tokyo, Japan
Ticker: D4S (Frankfurt Stock Exchange)
SEC: Daiichi Sankyo
Recent deal news: Daiichi Sankyo deal news at Current Partnering
Must read report: Partnering Deals and Alliances with Daiichi Sankyo
Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan.
Daiichi Sankyo Co. Ltd. was established in 2005 with the merger of two leading century-old pharmaceutical companies, Daiichi Pharmaceutical and Sankyo.
Headquartered in Tokyo, the company is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets.
Daiichi Sankyo maintains a portfolio of marketed pharmaceuticals for hypertension, hyperlipidemia, and bacterial infections around the world and also focuses on the discovery of novel oncology therapies.
The company strives to accomplish its vision by acquiring new product candidates, new products and/or companies that will drive its portfolio in key therapeutic categories. It is actively engaged in continuously improving its R&D processes for medicines in:
- Cardiovascular and Metabolic Disorders
- “Frontier” – innovative discoveries in a variety of mechanisms and diseases
Daiichi Sankyo has an active licensing venture investment and acquisition group charged with analysing and managing all incoming opportunities more
Daiichi Sankyo announced over 47 partnering / licensing deals since its inception in 2005, with atleast 10 deals in 2011 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in cardiovascular, cancer, followed by infectives and metabolic diseases more
Daiichi Sankyo has also announced 5 M&A deals since 2005, with the lead deals being the acquisition of Plexxikon, Zenotech and Ranbaxy Laboratories more
Top 50 pharma ranking*: 24
*based on reported global sale for year ending December 2013.
Total annual revenue
Total annual R&D spend
Top selling drugs
Available reports from Current Partnering
Report: Partnering Deals and Alliances with Daiichi Sankyo
Available resources for deal coverage for Daiichi Sankyo
Read: more on Daiichi Sankyo company profile, recent partnering, M&A and financing news and articles
Report: Practical Guide to Finding Partners
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk